Volume 2, Issue 6
Editorialp. 535
Future treatment of rheumatic diseases: the role of pharmacogenetics
Author(s): Jeffrey D Greenberg
Drug Evaluationp. 545
Update on the clinical pharmacology of etoricoxib, a potent cyclooxygenase-2 inhibitor
Author(s): Eduardo Collantes-Estevez
Review Articlep. 567
Opportunistic infections associated with TNF-α treatment
Author(s): Eric L Matteson
Review Articlep. 577
Amticyclic citrullinated peptide antibodies: the footprint of autoreactive plasma cells in synovium?
Author(s): Jacob M van Laar
Review Articlep. 599
Are complex therapies requires as pharmacological treatments of fibromyalgia?
Author(s): Kim Lawson
Review Articlep. 607
Osteoarthritis genetics: current status and future prospects
Author(s): James M Wilkins
